Oventus Manufacturing Pty, Ltd.

Oventus Manufacturing Pty, Ltd. specializes in mandible-repositioning sleep-disordered breathing orthoses, which are custom dental devices designed to reposition the lower jaw during sleep. These devices are primarily used to treat obstructive sleep apnea and related conditions by providing an alternative to CPAP therapy. The company’s portfolio includes adjustable and fixed designs, such as the O2Vent T, O2Vent Optima, and O2Vent Mono, tailored to different patient needs.

Oventus Manufacturing Pty, Ltd. is based in the United States, where its devices must comply with U.S. regulatory requirements. Since the company’s products fall under Class II classification, they require premarket notification (510(k)) submissions and must be listed in the FDA’s Unique Device Identifier (UDI) database to ensure authorization. The U.S. regulatory framework governs their development, manufacturing, and post-market surveillance.

Oventus Manufacturing Pty, Ltd.’s devices are listed in the FDA’s 510(k) premarket notification registry and the FDA’s UDI database. This inclusion is critical because Class II devices in the U.S. require formal submission and tracking to demonstrate compliance with regulatory standards. Listing in these registries ensures transparency, traceability, and adherence to FDA requirements for device authorization and post-market oversight.

Oventus Manufacturing Pty, Ltd.’s devices are classified as Class II under regulatory frameworks. This classification means they are considered to have moderate risk and require premarket notification (510(k)) submissions to the FDA to demonstrate safety and effectiveness. Unlike Class I devices (low risk), Class II devices undergo additional scrutiny to ensure proper performance before authorization, including compliance with specific performance standards and UDI registration.